A Multi-center Prospective Study on the Oncological and Reproductive Outcomes and Quality of Life in Young Woman After Fertility-sparing Treatment of Endometrial Cancer and Endometrial Intraepithelial Hyperplasia

ConditionsEndometrial Cancer Endometrial Intraepithelial Neoplasia Fertility-sparing Surgery

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

Age18-45

SponsorRegion Stockholm

About this trial

We will investigate the safety and efficiency of fertility-sapring treatment in ypung women witg endometrial cancer and endometrial intraepithelial hyperplasia

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Fertility sparing treatment of EC and EIN.

18-45 Years old

From start study (Jan 2025 - end study Jan 2028)

All centras in Sweden

Disqualifiers

Not English och Swedish speaking

Trial population

All women in Sweden

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

Relaps of endometrial cancer or EIN after fertility-sparing treatment

Time frame

from enrollment to 2 years after fertility-sparing treatment

Secondary outcomes

Live birth rate in women that has been treated with fertility-sparing treatment for EC or EIN

Time frame

From start of study to 2 years after fertility-sparing treatment

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Region Stockholm

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: